Correlation Between Airbus Group and Vytrus Biotech

Can any of the company-specific risk be diversified away by investing in both Airbus Group and Vytrus Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Airbus Group and Vytrus Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Airbus Group SE and Vytrus Biotech SA, you can compare the effects of market volatilities on Airbus Group and Vytrus Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Airbus Group with a short position of Vytrus Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Airbus Group and Vytrus Biotech.

Diversification Opportunities for Airbus Group and Vytrus Biotech

-0.45

Correlation Coefficient

Airbus Group  Vytrus Biotech

Very good diversification

The 3 months correlation between Airbus and Vytrus is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Airbus Group SE and Vytrus Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vytrus Biotech SA and Airbus Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Airbus Group SE are associated (or correlated) with Vytrus Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vytrus Biotech SA has no effect on the direction of Airbus Group i.e., Airbus Group and Vytrus Biotech go up and down completely randomly.

Pair Corralation between Airbus Group and Vytrus Biotech

Assuming the 90 days trading horizon Airbus Group SE is expected to generate 0.37 times more return on investment than Vytrus Biotech. However, Airbus Group SE is 2.69 times less risky than Vytrus Biotech. It trades about 0.2 of its potential returns per unit of risk. Vytrus Biotech SA is currently generating about -0.12 per unit of risk. If you would invest  13,046  in Airbus Group SE on September 13, 2024 and sell it today you would earn a total of  2,608  from holding Airbus Group SE or generate 19.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Airbus Group SE  vs.  Vytrus Biotech SA

Airbus Group SE

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Airbus Group SE are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Airbus Group exhibited solid returns over the last few months and may actually be approaching a breakup point.

Vytrus Biotech SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Airbus Group and Vytrus Biotech

The main advantage of trading using opposite Airbus Group and Vytrus Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Airbus Group position performs unexpectedly, Vytrus Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vytrus Biotech will offset losses from the drop in Vytrus Biotech's long position.

The idea behind Airbus Group SE and Vytrus Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.